228 related articles for article (PubMed ID: 26921331)
1. Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival.
den Hollander P; Rawls K; Tsimelzon A; Shepherd J; Mazumdar A; Hill J; Fuqua SA; Chang JC; Osborne CK; Hilsenbeck SG; Mills GB; Brown PH
Cancer Res; 2016 Apr; 76(7):1942-53. PubMed ID: 26921331
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.
Gari HH; Gearheart CM; Fosmire S; DeGala GD; Fan Z; Torkko KC; Edgerton SM; Lucia MS; Ray R; Thor AD; Porter CC; Lambert JR
Oncotarget; 2016 Mar; 7(13):15757-71. PubMed ID: 26909599
[TBL] [Abstract][Full Text] [Related]
3. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
Mazumdar A; Poage GM; Shepherd J; Tsimelzon A; Hartman ZC; Den Hollander P; Hill J; Zhang Y; Chang J; Hilsenbeck SG; Fuqua S; Kent Osborne C; Mills GB; Brown PH
Breast Cancer Res Treat; 2016 Aug; 158(3):441-54. PubMed ID: 27393618
[TBL] [Abstract][Full Text] [Related]
4. PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.
Gari HH; DeGala GD; Ray R; Lucia MS; Lambert JR
Cancer Lett; 2016 Oct; 380(2):505-512. PubMed ID: 27452906
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma.
Mayinuer A; Yasen M; Mogushi K; Obulhasim G; Xieraili M; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S
Ann Surg Oncol; 2013 Jan; 20(1):305-17. PubMed ID: 23064776
[TBL] [Abstract][Full Text] [Related]
6. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
7. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
[TBL] [Abstract][Full Text] [Related]
8. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
[TBL] [Abstract][Full Text] [Related]
9. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase.
Lazo JS; Blanco IK; Tasker NR; Rastelli EJ; Burnett JC; Garrott SR; Hart DJ; McCloud RL; Hsu KL; Wipf P; Sharlow ER
J Pharmacol Exp Ther; 2019 Dec; 371(3):652-662. PubMed ID: 31601683
[TBL] [Abstract][Full Text] [Related]
10. Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer.
Lazo JS; Sharlow ER; Cornelison R; Hart DJ; Llaneza DC; Mendelson AJ; Rastelli EJ; Tasker NR; Landen CN; Wipf P
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209460
[TBL] [Abstract][Full Text] [Related]
11. LRP8 is overexpressed in estrogen-negative breast cancers and a potential target for these tumors.
Maire V; Mahmood F; Rigaill G; Ye M; Brisson A; Némati F; Gentien D; Tucker GC; Roman-Roman S; Dubois T
Cancer Med; 2019 Jan; 8(1):325-336. PubMed ID: 30575334
[TBL] [Abstract][Full Text] [Related]
12. Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.
Zimmerman MW; McQueeney KE; Isenberg JS; Pitt BR; Wasserloos KA; Homanics GE; Lazo JS
J Biol Chem; 2014 Feb; 289(9):5904-13. PubMed ID: 24403062
[TBL] [Abstract][Full Text] [Related]
13. ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis.
Zhang X; Mu X; Huang O; Wang Z; Chen J; Chen D; Wang G
BMC Cancer; 2022 Mar; 22(1):226. PubMed ID: 35236318
[TBL] [Abstract][Full Text] [Related]
14. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
15. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) promotes the aggressiveness of human uveal melanoma through dephosphorylation of CRMP2.
Duciel L; Anezo O; Mandal K; Laurent C; Planque N; Coquelle FM; Gentien D; Manneville JB; Saule S
Sci Rep; 2019 Feb; 9(1):2990. PubMed ID: 30816227
[TBL] [Abstract][Full Text] [Related]
17. USP2 promotes cell migration and invasion in triple negative breast cancer cell lines.
Qu Q; Mao Y; Xiao G; Fei X; Wang J; Zhang Y; Liu J; Cheng G; Chen X; Wang J; Shen K
Tumour Biol; 2015 Jul; 36(7):5415-23. PubMed ID: 25687182
[TBL] [Abstract][Full Text] [Related]
18. Effect of protein-tyrosine phosphatase 4A3 by small interfering RNA on the proliferation of lung cancer.
Lian YX; Chen R; Xu YH; Peng CL; Hu HC
Gene; 2012 Dec; 511(2):169-76. PubMed ID: 23036709
[TBL] [Abstract][Full Text] [Related]
19. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
Reed DE; Shokat KM
Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
[TBL] [Abstract][Full Text] [Related]
20. The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth.
Qian J; Ma Y; Tahaney WM; Moyer CL; Lanier A; Hill J; Coleman D; Koupaei N; Hilsenbeck SG; Savage MI; Page BDG; Mazumdar A; Brown PH
Breast Cancer Res; 2024 Feb; 26(1):23. PubMed ID: 38317231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
